Top Markets
Coin of the day
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Peringkat dalam Saham #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Harga Saham
$0.108
Terakhir disinkronkan: 2023-01-23
Kapitalisasi Pasar
$4.56M
Perubahan (1 hari)
-10.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Tricida, Inc. (TCDA)

Kategori

Riwayat hasil dividen untuk Tricida, Inc. (TCDA)
Hasil dividen (TTM) dari Tricida, Inc. (simbol saham: TCDA) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Tricida, Inc. (TCDA) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing